ZA93436B - Benzopyran derivatives - Google Patents
Benzopyran derivativesInfo
- Publication number
- ZA93436B ZA93436B ZA93436A ZA93436A ZA93436B ZA 93436 B ZA93436 B ZA 93436B ZA 93436 A ZA93436 A ZA 93436A ZA 93436 A ZA93436 A ZA 93436A ZA 93436 B ZA93436 B ZA 93436B
- Authority
- ZA
- South Africa
- Prior art keywords
- represent
- hydroxy
- benzopyran derivatives
- hydrogen
- formula
- Prior art date
Links
- 150000001562 benzopyrans Chemical class 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 230000003556 anti-epileptic effect Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- -1 hydroxy, substituted amino Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1081992 | 1992-01-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA93436B true ZA93436B (en) | 1993-08-25 |
Family
ID=11760967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA93436A ZA93436B (en) | 1992-01-24 | 1993-01-21 | Benzopyran derivatives |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5646308A (xx) |
| EP (1) | EP0632033B1 (xx) |
| JP (1) | JP3260458B2 (xx) |
| KR (1) | KR100217167B1 (xx) |
| CN (1) | CN1036918C (xx) |
| AT (1) | ATE178601T1 (xx) |
| AU (1) | AU3367393A (xx) |
| CA (1) | CA2128603A1 (xx) |
| DE (1) | DE69324354T2 (xx) |
| DK (1) | DK0632033T3 (xx) |
| ES (1) | ES2132217T3 (xx) |
| GR (1) | GR3030581T3 (xx) |
| SG (1) | SG52734A1 (xx) |
| WO (1) | WO1993015068A1 (xx) |
| ZA (1) | ZA93436B (xx) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5428031A (en) * | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
| DE69422038T2 (de) * | 1993-04-23 | 2000-09-14 | Chugai Seiyaku K.K., Tokio/Tokyo | Benzopyranderivate |
| US5719155A (en) * | 1993-11-10 | 1998-02-17 | Japan Tobacco Inc. | Chroman derivative and pharmaceutical use thereof |
| HU220635B1 (hu) * | 1994-08-18 | 2002-03-28 | Merck & Co. Inc. | 2,3-Dihidro-1-(2,2,2-trifluor-etil)-2-oxo-5-fenil-1H-1,4-benzodiazepin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására |
| US5631251A (en) * | 1995-06-07 | 1997-05-20 | Merck & Co., Inc. | 5-cyclopropyl-1,4 benzodiazepine-2-ones |
| US5700797A (en) * | 1995-06-07 | 1997-12-23 | Merck & Co, Inc. | N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides |
| US5726171A (en) * | 1995-06-07 | 1998-03-10 | Merck & Co Inc | N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides |
| AU720378B2 (en) * | 1995-06-07 | 2000-06-01 | Merck & Co., Inc. | Novel N-(4-oxo-2,3,4,5-tetrahydro-1H-1, 5-benzodiazepin-3yl)-3-amides |
| US5691331A (en) * | 1995-06-07 | 1997-11-25 | Merck & Co., Inc. | N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides |
| AU3867997A (en) * | 1996-08-27 | 1998-03-19 | Shionogi & Co., Ltd. | Chromene-3-carboxylate derivatives |
| FR2756284B1 (fr) * | 1996-11-26 | 2000-04-28 | Adir | Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TW533073B (en) * | 1997-03-03 | 2003-05-21 | Chugai Pharmaceutical Co Ltd | Therapeutic agents for peripheral vascular disease |
| ES2251095T3 (es) * | 1997-08-08 | 2006-04-16 | Chugai Seiyaku Kabushiki Kaisha | Agentes terapeuticos para complicaciones diabeticas. |
| KR20010085866A (ko) * | 1998-09-30 | 2001-09-07 | 나가야마 오사무 | 4-치환 벤조피란 유도체의 제조법 |
| CZ20013076A3 (cs) * | 2000-08-29 | 2002-04-17 | Kuraray Co., Ltd. | Způsob výroby chromankarboxylové kyseliny |
| KR100602191B1 (ko) * | 2004-03-10 | 2006-07-19 | 한국화학연구원 | 5-라이폭시게네이즈 저해활성을 가지는2,2'-이중치환-3,4-디하이드로-7,8-이중치환-6-알킬아미노벤조피란 유도체 |
| JP2007536302A (ja) * | 2004-05-05 | 2007-12-13 | エフ．ホフマン−ラ ロシュ アーゲー | ５−ｈｔ６受容体、５−ｈｔ２ａ受容体、又はその両方の調節に有用なアリールスルホニルベンゾジオキサン類 |
| CN101006081B (zh) | 2004-07-30 | 2011-02-09 | 托伦特药物有限公司 | 奈必洛尔及其药学可接受盐、制备方法以及奈必洛尔的药物组合物 |
| MX2007007481A (es) * | 2004-12-21 | 2007-07-20 | Hoffmann La Roche | Derivados de tetralina e indano y usos de los mismos. |
| HRP20100181T1 (hr) * | 2004-12-21 | 2010-05-31 | F. Hoffmann - La Roche Ag | Derivati tetralina i indana i njihove upotrebe |
| ATE409179T1 (de) * | 2004-12-21 | 2008-10-15 | Hoffmann La Roche | Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten |
| WO2006066746A1 (en) * | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Chroman derivatives and their use as 5-ht receptor ligands |
| CA2591810A1 (en) | 2004-12-21 | 2006-06-29 | F.Hoffmann-La Roche Ag | Chroman derivatives and uses thereof in the treatment of cns disorders |
| KR100704009B1 (ko) * | 2005-08-30 | 2007-04-04 | 한국화학연구원 | 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체 |
| ATE499355T1 (de) * | 2005-11-03 | 2011-03-15 | Hoffmann La Roche | Arylsulfonylchromane als 5-ht6-inhibitoren |
| MX2008015510A (es) * | 2006-06-20 | 2008-12-18 | Hoffmann La Roche | Derivados de arilsulfonamidiltetralina y usos de los mismos. |
| MX2008015511A (es) * | 2006-06-20 | 2008-12-18 | Hoffmann La Roche | Derivados de arilsulfonilnaftaleno y usos de los mismos. |
| CN101472884A (zh) * | 2006-06-20 | 2009-07-01 | 弗·哈夫曼-拉罗切有限公司 | 1,2,3,4-四氢化萘和茚满衍生物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH619701A5 (xx) * | 1975-08-07 | 1980-10-15 | Bayer Ag | |
| JPS57167981A (en) * | 1981-04-08 | 1982-10-16 | Kowa Co | Benzopyran derivative |
| GB8911280D0 (en) * | 1989-05-17 | 1989-07-05 | Beecham Group Plc | Novel compounds |
| ATE161254T1 (de) * | 1990-07-27 | 1998-01-15 | Chugai Pharmaceutical Co Ltd | Benzopyranderivat |
-
1993
- 1993-01-21 ZA ZA93436A patent/ZA93436B/xx unknown
- 1993-01-22 CN CN93102056A patent/CN1036918C/zh not_active Expired - Fee Related
- 1993-01-22 JP JP00942193A patent/JP3260458B2/ja not_active Expired - Fee Related
- 1993-01-25 CA CA002128603A patent/CA2128603A1/en not_active Abandoned
- 1993-01-25 AT AT93902526T patent/ATE178601T1/de not_active IP Right Cessation
- 1993-01-25 DK DK93902526T patent/DK0632033T3/da active
- 1993-01-25 EP EP93902526A patent/EP0632033B1/en not_active Expired - Lifetime
- 1993-01-25 SG SG1996008501A patent/SG52734A1/en unknown
- 1993-01-25 US US08/256,580 patent/US5646308A/en not_active Expired - Fee Related
- 1993-01-25 KR KR1019940702541A patent/KR100217167B1/ko not_active Expired - Fee Related
- 1993-01-25 WO PCT/JP1993/000086 patent/WO1993015068A1/ja not_active Ceased
- 1993-01-25 DE DE69324354T patent/DE69324354T2/de not_active Expired - Fee Related
- 1993-01-25 ES ES93902526T patent/ES2132217T3/es not_active Expired - Lifetime
- 1993-01-25 AU AU33673/93A patent/AU3367393A/en not_active Abandoned
-
1999
- 1999-06-22 GR GR990401664T patent/GR3030581T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1077954A (zh) | 1993-11-03 |
| SG52734A1 (en) | 1998-09-28 |
| WO1993015068A1 (fr) | 1993-08-05 |
| DE69324354T2 (de) | 1999-11-25 |
| JP3260458B2 (ja) | 2002-02-25 |
| AU3367393A (en) | 1993-09-01 |
| US5646308A (en) | 1997-07-08 |
| KR950700277A (ko) | 1995-01-16 |
| ATE178601T1 (de) | 1999-04-15 |
| CA2128603A1 (en) | 1993-08-05 |
| ES2132217T3 (es) | 1999-08-16 |
| GR3030581T3 (en) | 1999-10-29 |
| JPH05294954A (ja) | 1993-11-09 |
| EP0632033A1 (en) | 1995-01-04 |
| EP0632033A4 (xx) | 1995-02-01 |
| EP0632033B1 (en) | 1999-04-07 |
| DK0632033T3 (da) | 1999-10-18 |
| DE69324354D1 (de) | 1999-05-12 |
| CN1036918C (zh) | 1998-01-07 |
| KR100217167B1 (ko) | 1999-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA93436B (en) | Benzopyran derivatives | |
| TW258735B (xx) | ||
| FR15C0027I1 (xx) | ||
| MY113732A (en) | Arylthio compounds | |
| KR0184608B1 (en) | Novel benzopyran derivative | |
| PT947504E (pt) | Derivados de vitamina d 16-eno | |
| SG47557A1 (en) | Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents | |
| DK0688212T3 (da) | C9-taxanderivater og farmaceutiske præparater indeholdende disse | |
| ZA881430B (xx) | ||
| ATE72445T1 (de) | 4'-epi-4'-aminoanthracycline. | |
| TW243446B (xx) | ||
| AU2474488A (en) | Photochromatic composition and photochromatic articles which contain it | |
| ATE100996T1 (de) | Blattglanzmittel. | |
| EP0657412A4 (xx) | ||
| EP0721957A4 (en) | THE CONNECTION GE3 | |
| EP0659752A4 (xx) | ||
| DK0456514T3 (da) | 2-Fluorneplanocin A og dets fremstilling |